• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

John Hancock, Verily and Onduo Launch John Hancock Aspire, The First Life Insurance Solution Designed for Americans Living with Diabetes

Share:

November 4, 2019

John Hancock announced John Hancock Aspire™ with Vitality, the first of its kind life insurance designed specifically for Americans living with diabetes, in collaboration with Verily, an Alphabet company, and Onduo.

Diabetes remains the seventh leading cause of death in the United States, with 1.5 million Americans diagnosed every year.1 Of the more than 30 million Americans living with diabetes, half either don’t have enough life insurance or don’t have any life insurance coverage at all.2,3 Many worry they won’t qualify for a life insurance policy because they have diabetes, and if they can secure coverage they are worried it’s too expensive.3 Further, even those with quality healthcare don’t always have access to state-of-the-art, personalized diabetes management support.

John Hancock Aspire offers customers living with diabetes the protection of life insurance paired with a technology-enabled program that provides coaching, clinical support, education, and rewards designed to help manage and improve their health.* All John Hancock Aspire customers will also have access to an enhanced version of John Hancock Vitality, which is designed to reward steps customers take toward living longer, healthier lives, like exercise and buying healthy food, and now offers opportunities specific to the diabetes journey. Members have the potential to save up to 25 percent on their premiums.**

Qualifying John Hancock Aspire customers with type 2 diabetes will be eligible to access Onduo’s virtual clinic and receive a blood glucose monitoring device which, when used in conjunction with the Onduo app, provide insights into the user’s diabetes management. Onduo’s virtual care team, made up of diabetes professionals such as dieticians, diabetes educators and doctors, offers personalized guidance and support regarding diet, activity, lifestyle habits and medication management. Those using Onduo to manage and improve their health can earn points to further boost their overall Vitality rewards and lower their premiums.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“The life insurance industry hasn’t traditionally served people living with diabetes well, when actually, we’re among the most uniquely positioned to help improve their health outcomes because our customer relationships often last a lifetime,” said Brooks Tingle, President and CEO of John Hancock Insurance. “At John Hancock, we believe in helping customers live longer, healthier lives, whether they’re living with a chronic condition like diabetes, or not. When we help customers manage their diabetes by providing virtual care, education, support, incentives and rewards, we’re not only creating value for them, but also for our industry and society as a whole. That’s why we’re thrilled to work with innovative industry leaders, Verily and Onduo, to offer access to people living with diabetes to this first-of-its-kind offering. It’s time our industry started delivering more tailor-made solutions that truly help our customers.”

“This dynamic partnership with John Hancock unlocks the full potential for the Onduo platform, empowering people living with Type 2 diabetes to co-produce their own health at home and in mobile environments and rewards them for doing so,” said Andy Conrad, CEO, Verily. “Through this initiative, Verily and John Hancock are pushing the envelope on the role life insurance can play in both providing financial security and helping people live longer, healthier lives.”

John Hancock has been committed to providing access to life insurance for customers with diabetes for decades. In 2018, 88 percent of applicants living with type 2 diabetes were approved for coverage.4 John Hancock Aspire is an opportunity to empower people living with diabetes further by giving them tools and resources to help them improve their health and change their lives.

John Hancock Aspire will be available to customers on November 18, 2019. For more information about John Hancock Aspire, visit JHAspire.com.

Source: Markets Insider

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • List of Obamacare Taxes Repealed in Senate Health BillList of Obamacare Taxes Repealed in Senate Health Bill
  • Sartorius Signs Agreement to Acquire Select Danaher Life Science Platform BusinessesSartorius Signs Agreement to Acquire Select Danaher Life Science Platform Businesses
  • AstraZeneca to Acquire Alexion, Accelerating the Company’s Strategic and Financial DevelopmentAstraZeneca to Acquire Alexion, Accelerating the Company’s Strategic and Financial Development
  • Fitbit Receives $2.5M Award from Army for COVID-19 Early DetectionFitbit Receives $2.5M Award from Army for COVID-19 Early Detection
  • Grand Rapids Launches Initiative to End Homelessness by Addressing Social Determinants of HealthGrand Rapids Launches Initiative to End Homelessness by Addressing Social Determinants of Health
  • Synlogic and Ginkgo Bioworks Establish Transformational Platform Collaboration for the Accelerated Development of Novel Synthetic Biotic™ MedicinesSynlogic and Ginkgo Bioworks Establish Transformational Platform Collaboration for the Accelerated Development of Novel Synthetic Biotic™ Medicines
  • Global Lecithin Supplements Market Insights Report 2019-2025 – Jamieson, Robinson Pharma, Inc., Weihai Baihe Biology, NOW Foods, SolgarGlobal Lecithin Supplements Market Insights Report 2019-2025 – Jamieson, Robinson Pharma, Inc., Weihai Baihe Biology, NOW Foods, Solgar
  • FDA Approves COVID-19 Oral Fluid Test For Use NationwideFDA Approves COVID-19 Oral Fluid Test For Use Nationwide

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications